147816-24-8 Cefcapene pivoxil hydrochloride monohydrate AKSci Q717
 
 
Loading Please Wait...
  Q717    
Cefcapene pivoxil hydrochloride monohydrate
, 98% (HPLC)
 



IDENTITY
CAS Number:147816-24-8
MDL Number:MFCD01682041
MF:C23H29N5O8S2.HCl.H2O
MW:622.11
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:158-164°C
Optical Rotation:+49° - +54° (c=1, MeOH)
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:Other solvents(Soluble): Methanol, Ethanol, Dimethylformamide(DMF)
Form:HCl salt

REVIEW

 Cefcapene pivoxil hydrochloride monohydrate is an orally-available, broad-spectrum, prodrug cephalosporin antibiotic. It is a prodrug ester which upon hydrolysis releases the active cefcapene acid that inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs). This inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.

REFERENCES
[1]Hamashima, Yoshio; Tanaka, Mamoru; Haneshima, Makoto Preparation of antibiotic 7-beta-[(Z)-2-(2-amino-4-thiazolyl)-2-pentenoylamino]-3-carbamoyloxymethyl-cephem-4-carboxylic acid pivaloyloxylmethyl ester hydrochloride hydrate crystal suitable for oral administration. Jpn. Kokai Tokkyo Koho (1992), JP 04295485 A 19921020.
[2] Uenaka, Masaaki; Ide, Yutaka; Wakahara, Shigeru; Nishidate, Osamu Cefcapene pivoxil methanesulfonate in the preparation of cefcapene pivoxil hydrochloride hydrate PCT Int. Appl. (2006), WO 2006080484 A1 20060803.
[3] Shi, Zhifeng; Cui, Jiechen; Gu, Shichong; Wang, Guangming Improved method for synthesis of Cefcapene pivoxil hydrochloride hydrate From Faming Zhuanli Shenqing (2010), CN 101851249 A 20101006.
[4] Jiang, Jian-An; Zhai, Jiao-Jiao; Yu, Xin-Hong; Teng, Xin; Ji, Ya-Fei A practical synthesis of cefcapene pivoxil Synthesis (2012), 44(2), 207-214.
[5] Sakata H.Comparative study of 5-day cefcapene-pivoxil and 10-day amoxicillin or cefcapene-pivoxil for treatment of group A streptococcal pharyngitis in children. J Infect Chemother. 2008 Jun;14(3):208-12.
[6] Toyonaga Y, Iwai N, Motohiro T, Sunakawa K, Fujii R. PK/PD breakpoints and clinical/bacteriological effects of cefcapene pivoxil fine granules for children at free drug concentrations in pediatric patients with respiratory infection]. Jpn J Antibiot. 2008 Jun;61(3):172-83.
[7] Lee JE, Han DH, Won TB, Rhee CS. A Randomized, Double-blinded, Open Label Study of the Efficacy and Safety of Cefcapene Pivoxil and Amoxicillin·Clavulanate in Acute Presumed Bacterial Rhinosinusitis. Clin Exp Otorhinolaryngol. 2011 Jun;4(2):83-7.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
None

Hazard Statements
None

Precautionary Statements
Notavailable


Current as of April 23, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Antibacterials, Cephalosporins


PubChem
  @PubMed